Presentation is loading. Please wait.

Presentation is loading. Please wait.

Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home.

Published byLeena Halttunen Modified over 5 years ago

Similar presentations

Presentation on theme: "Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home."— Presentation transcript:

1 Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home hemodialysis (HHD) training between January 1, 2011 and December 31, 2014. Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home hemodialysis (HHD) training between January 1, 2011 and December 31, Outcomes included patient exits where the primary reason was medical instability, patient burnout, or care partner burnout; 1-, 2-, and 5-year technique survival rates were 94.2%, 74.8%, and 38.6%, respectively. Nikhil Shah et al. CJASN 2017;12: ©2017 by American Society of Nephrology

Download ppt "Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home."

Similar presentations

Volume 55, Issue 4, Pages (April 1999)

Volume 55, Issue 4, Pages (April 1999)
Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.
Beta blockers in the management of chronic kidney disease

Beta blockers in the management of chronic kidney disease
Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.
Suggested approach to patients with dabigatran-associated bleeding

Suggested approach to patients with dabigatran-associated bleeding
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.

Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Kaplan–Meier curve for the time until the development of lung cancer in patients with idiopathic pulmonary fibrosis. Kaplan–Meier curve for the time until.

Kaplan–Meier curve for the time until the development of lung cancer in patients with idiopathic pulmonary fibrosis. Kaplan–Meier curve for the time until.
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.

The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.

Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.
Volume 73, Issue 4, Pages (February 2008)

Volume 73, Issue 4, Pages (February 2008)
Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.

Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.
Kaplan–Meier curves of long-term survival in young (

Kaplan–Meier curves of long-term survival in young (
Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.

Incidence of in-hospital mortality rates are lower in rapid correction rate group versus slow correction rate group but not significantly different by.
Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.
Volume 71, Issue 12, Pages (June 2007)

Volume 71, Issue 12, Pages (June 2007)

Similar presentations

Ads by Google